Scientists have determined the atomic structure of the “binding” between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.
Scientists have determined the atomic structure of the “binding” between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.